Credit Agreements in the Pharmaceuticals Industry

374 Contracts & Agreements

Browse by Company

Acer Therapeutics Inc. (7 contracts)
Acreage Holdings, Inc. (8)
Adamis Pharmaceuticals Corp (3)
AERIE PHARMACEUTICALS INC (1)
AGILE THERAPEUTICS INC (16)
Akorn (21)
Allergan, plc (2)
Altus Pharmaceuticals Inc. (1)
Amag Pharmaceuticals (1)
Amneal Pharmaceuticals, Inc. (2)
Amphastar Pharma (6)
ANGIOTECH PHARMACEUTICALS INC (6)
Anthera Pharmaceuticals Inc (1)
APP Pharmaceuticals, Inc. (2)
APRICUS BIOSCIENCES, INC. (1)
Aquestive Therapeutics, Inc. (4)
Aralez Pharmaceuticals Inc. (2)
ARIAD PHARMACEUTICALS INC (7)
AVALON PHARMACEUTICALS INC (1)
AVENUE THERAPEUTICS, INC. (1)
Axsome Therapeutics, Inc. (1)
AYTU BIOSCIENCE, INC (1)
BARR PHARMACEUTICALS INC (6)
Baudax Bio, Inc. (7)
Bausch Health Companies Inc. (11)
BIODELIVERY SCIENCES INTERNATIONAL INC (2)
Biofrontera Inc. (1)
BioPharmX Corp (1)
BODY & MIND INC. (4)
Bohai Pharmaceuticals Group, Inc. (1)
BRADLEY PHARMACEUTICALS INC (1)
Bright Green Corp (5)
Bristol-Myers Squibb (24)
Canopy Growth Corp (1)
Catalent Inc (5)
CELGENE CORP (4)
Cerecor Inc. (2)
Cronos Group Inc. (1)
Endo International plc (2)
Eton Pharmaceuticals, Inc. (4)
EyePoint Pharmaceuticals, Inc. (1)
Foamix Pharmaceuticals Ltd. (4)
Fresenius Kabi Pharmaceuticals Holding, Inc. (3)
Green Thumb Industries Inc. (1)
GUILFORD PHARMACEUTICALS INC (1)
Harmony Biosciences Holdings, Inc. (1)
Haymaker Acquisition Corp. III (3)
Horizon Pharma plc (1)
iANTHUS CAPITAL HOLDINGS, INC. (1)
Jaguar Health, Inc. (3)
Jazz Pharmaceuticals plc (2)
Kaleido Biosciences, Inc. (2)
Kedem Pharmaceuticals Inc. (1)
KEMPHARM, INC (1)
KID CASTLE EDUCATIONAL CORP (1)
KOS PHARMACEUTICALS INC (2)
Lannett Company, Inc. (4)
Liquidia Corp (2)
Mallinckrodt (1)
MARINUS PHARMACEUTICALS INC (1)
Medicine Man Technologies, Inc. (1)
MedMen Enterprises, Inc. (1)
Menlo Therapeutics Inc. (5)
Merck (1)
MiddleBrook Pharmaceuticals, Inc. (1)
Molecular Insight Pharmaceuticals, Inc. (1)
Mylan N.V. (17)
Neos Therapeutics, Inc. (2)
NEW RIVER PHARMACEUTICALS INC (1)
NOVEN PHARMACEUTICALS INC (2)
OCULAR THERAPEUTIX, INC (10)
OptiNose, Inc. (6)
Pacira Pharmaceuticals, Inc. (1)
PENWEST PHARMACEUTICALS CO (1)
Perrigo (3)
Pfizer (2)
Phibro Animal Health Corporation (7)
Prestige Brands Holdings Inc (1)
Processa Pharmaceuticals, Inc. (4)
Recro Pharma, Inc. (16)
Reliant Pharmaceuticals, Inc. (3)
Roivant Sciences Ltd. (1)
Royalty Pharma plc (2)
Sagent Pharmaceuticals, Inc. (11)
SALIX PHARMACEUTICALS LTD (2)
SANCILIO PHARMACEUTICALS COMPANY, INC. (3)
scPharmaceuticals Inc. (3)
SIGA TECHNOLOGIES INC (3)
Supernus Pharmaceuticals, Inc. (1)
TerrAscend Corp. (4)
TEVA PHARMACEUTICAL INDUSTRIES LTD (4)
TherapeuticsMD, Inc. (2)
Tilray, Inc. (11)
Tribute Pharmaceuticals Canada Inc. (1)
Upjohn Inc (2)
VALEANT PHARMACEUTICALS INTERNATIONAL (1)
Valera Pharmaceuticals Inc (1)
Verrica Pharmaceuticals Inc. (6)
Vireo Health International, Inc. (8)
Zoetis (7)
Zomedica Pharmaceuticals Corp. (2)

Recent Contracts

Fifth Amendment to Credit Agreement by and among the Company and SWK Funding LLC dated as of September 30, 2024 (Eton Pharmaceuticals, Inc., Filed With SEC on November 12, 2024)
Fifth Amendment to Credit Agreement, dated as of August 2, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Verrica Pharmaceuticals Inc., Filed With SEC on November 5, 2024)
Fourth Amendment and Consent to Credit Agreement, dated as of October 30, 2024 (Tilray, Inc., Filed With SEC on November 1, 2024)
Non-Revolving Credit Note issued favor of Bengal Catalyst Fund, LP, dated October 24, 2024 (BODY & MIND INC., Filed With SEC on October 30, 2024)
Non-Revolving Credit Facility Agreement by and between Body and Mind Inc. and Bengal Catalyst Fund, LP, dated October 24, 2024 (BODY & MIND INC., Filed With SEC on October 30, 2024)
Secured Amended and Restated Line of Credit Note dated September 16, 2024, between Bright Green Corporation and Lynn Stockwell (Bright Green Corp, Filed With SEC on September 18, 2024)
Credit Agreement, dated September 11, 2024 (Green Thumb Industries Inc., Filed With SEC on September 13, 2024)
Secured Amended and Restated Line of Credit Note, dated as of August 19, 2024 (Bright Green Corp, Filed With SEC on August 19, 2024)
Fifth Amendment to Credit Agreement, dated as of August 2, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Verrica Pharmaceuticals Inc., Filed With SEC on August 14, 2024)
Fourth Amendment to Credit Agreement, dated as of June 26, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Verrica Pharmaceuticals Inc., Filed With SEC on August 14, 2024)
Third Amendment to Credit Agreement, dated as of May 6, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Verrica Pharmaceuticals Inc., Filed With SEC on August 14, 2024)
Credit Agreement and Guaranty, by and among the Company, the guarantors from time to time party thereto, the lenders from time to time party thereto and Perceptive Credit Holdings... (scPharmaceuticals Inc., Filed With SEC on August 12, 2024)
Warrant, dated August 9, 2024, issued by the Company to Perceptive Credit Holdings IV, LP (scPharmaceuticals Inc., Filed With SEC on August 12, 2024)
Second Amendment to Credit agreement, dated as of June 26, 2024, by and among BioTE Medical, LLC, BioTE Holdings, LLC, other guarantors party therein, the lenders party therein,... (Haymaker Acquisition Corp. III, Filed With SEC on August 9, 2024)
First Amendment and Waiver to Credit agreement, dated as of April 26, 2024, by and among BioTE Medical, LLC, BioTE Holdings, LLC, other guarantors party therein, the lenders party... (Haymaker Acquisition Corp. III, Filed With SEC on August 9, 2024)
Amendment No. 3 to Credit Agreement, dated as of August 8, 2024, between Canopy Growth Corporation, 11065220 Canada Inc., the lenders party thereto and Wilmington Trust, National... (Canopy Growth Corp, Filed With SEC on August 9, 2024)
First Amendment to Credit Agreement by and among Dermavant Sciences Ltd., Dermavant Holdings Limited, Dermavant Sciences IRL Limited, Dermavant Sciences GmbH, certain subsidiaries... (Roivant Sciences Ltd., Filed With SEC on August 9, 2024)
Eighth Amendment to Credit Agreement, dated as of June 14, 2024, by and among Goodness Growth Holdings, Inc. and certain of its subsidiaries, the persons from time-to-time parties... (Vireo Health International, Inc., Filed With SEC on August 6, 2024)
Seventh Amendment to Credit Agreement, dated as of April 30, 2024, by and among Goodness Growth Holdings, Inc. and certain of its subsidiaries, the persons from time-to-time... (Vireo Health International, Inc., Filed With SEC on August 6, 2024)
Amended and Restated Credit Agreement, dated as of June 20, 2024, by and among Cronos Growing Company Inc., as Borrower, the Lenders from time to time parties thereto and Peace... (Cronos Group Inc., Filed With SEC on June 25, 2024)
CREDIT AGREEMENT Dated as of April 5, 2024 among ZEVRA THERAPEUTICS, INC., as the Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER, as Guarantors, ALTER DOMUS (US) LLC, as the... (KEMPHARM, INC, Filed With SEC on May 9, 2024)
Second Amendment to Senior Unsecured Sustainability-Linked Revolving Credit Agreement, dated May 3, 2024, by and among Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals... (TEVA PHARMACEUTICAL INDUSTRIES LTD, Filed With SEC on May 8, 2024)
First Amendment, dated as of May 8, 2024, to Credit Agreement, dated as of March 31, 2023, by and among Pacira BioSciences, Inc., the lenders from time to time party thereto and... (Pacira Pharmaceuticals, Inc., Filed With SEC on May 8, 2024)
Second Amendment to Credit and Security Agreement, dated as of March 28, 2024, amending the Credit and Security Agreement, dated June 30, 2023, by and among Bausch Receivables... (Bausch Health Companies Inc., Filed With SEC on May 2, 2024)
Amended and Restated Credit Agreement, dated as of March 14, 2024, by and among Aphria Diamond Inc., Aphria Inc., the Company, Bank of Montreal and the Guarantors and Lenders... (Tilray, Inc., Filed With SEC on April 9, 2024)
Third Amendment and Consent to Credit Agreement, dated as of March 29, 2024, by and among American Beverage Crafts Group, Inc. (formerly known as Four Twenty Corporation), Bank of... (Tilray, Inc., Filed With SEC on April 9, 2024)
Waiver to Credit Agreement, dated as of January 5, 2024, by and between Four Twenty Corporation, Bank of America, N.A., and the Guarantors and Lenders party thereto (incorporated... (Tilray, Inc., Filed With SEC on April 9, 2024)
Credit Agreement dated March 14, 2024 (Bright Green Corp, Filed With SEC on March 19, 2024)
Second Amendment to Credit Agreement, dated as of January 31, 2024, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP (Verrica Pharmaceuticals Inc., Filed With SEC on February 29, 2024)
First Amendment to Credit Agreement, dated as of December 20, 2023, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP (Verrica Pharmaceuticals Inc., Filed With SEC on February 29, 2024)
Eighth Amendment to Credit Agreement and Guaranty, by and among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (AGILE THERAPEUTICS INC, Filed With SEC on February 15, 2024)
Waiver to Credit Agreement, dated as of January 5, 2024, by and between Four Twenty Corporation, Bank of America, N.A., and the Guarantors and Lenders party thereto (Tilray, Inc., Filed With SEC on January 9, 2024)
Amended and Restated Revolving Credit Agreement, dated as of September 15, 2021, as amended by Amendment No. 1, dated as of October 31, 2022, as amended by Amendment No. 2, dated... (Royalty Pharma plc, Filed With SEC on December 27, 2023)
Seventh Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party thereto and... (AGILE THERAPEUTICS INC, Filed With SEC on December 11, 2023)
Amendment to Warrants and Certificate of Adjustment between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of October 30, 2023 (AGILE THERAPEUTICS INC, Filed With SEC on December 11, 2023)
Amendment No. 10 to Amended and Restated Credit Agreement, dated as of November 22, 2023, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JPMorgan... (Catalent Inc, Filed With SEC on November 27, 2023)
Form of DIP Credit Agreement, to be entered intoby the Company, Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO USHolding, Inc (BioPharmX Corp, Filed With SEC on November 17, 2023)
Convertible Credit Facility Agreement by and among NMG IL 4, LLC and DEP Nevada, Inc., dated December 26, 2019 (BODY & MIND INC., Filed With SEC on November 14, 2023)
Convertible Credit Facility Agreement by and among NMG IL 1, LLC and DEP Nevada, Inc., dated December 26, 2019 (BODY & MIND INC., Filed With SEC on November 14, 2023)
Credit and Security Agreement, dated August 2, 2023, by and among Barings Finance LLC, as administrative agent, the Registrant, and the Lenders listed therein (OCULAR THERAPEUTIX, INC, Filed With SEC on November 7, 2023)